13.300
+0,00%
2026-10-16
Fundamental Analysis
89 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +19894.8% | +21514.3% | 3 / 3 | -24.2% | +15.80 pp | +33.19 pp | +21.2% | 0.57 | 3.51 | 146 | −24,2% | 48,6 | +19.894,8% | 3.51 | 8.83 | −60,2% |
| Pts | 12 | 12 | 12 | 0 | 12 | 12 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 13.300 (close price on 2026-10-16)EPS (TTM): 3.784
Financial charts
1.Revenue & growth
VND bn146Q2/26
1.Revenue & growth
VND bn146Q2/26
2.Profit & growth
VND bn48,6Q2/26
3.Profit mix (Penman)
VND bn161Q2/26
4.Margins & cost structure
%6.5%Q2/26
5.Returns & cash cycle
% · days-0.7%Q2/26
6.Earnings quality & cash
VND bn59,1Q2/26
7.Asset structure
VND bn1.147Q2/26
8.Funding & debt health
VND bn · times1.147Q2/26
9.Revenue backlog
VND bn7,81Q2/26
10.Valuation
times · %3,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.430Q2/26
Adjusted EPS growth, latest quarter
199,9× higher
Average adjusted EPS growth, 3 quarters
216,1× higher
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26